光正眼科
(002524)
| 流通市值：23.75亿 | | | 总市值：23.96亿 |
| 流通股本：5.11亿 | | | 总股本：5.15亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 663,491,611.66 | 436,153,289.26 | 208,167,536.89 | 892,842,271.65 |
| 营业收入 | 663,491,611.66 | 436,153,289.26 | 208,167,536.89 | 892,842,271.65 |
| 二、营业总成本 | 669,323,200.43 | 438,708,944.32 | 210,803,000.59 | 937,439,817.91 |
| 营业成本 | 421,943,003.8 | 272,063,851.98 | 129,879,287.6 | 563,895,680.2 |
| 税金及附加 | 3,929,157.63 | 2,317,461.89 | 1,364,467.6 | 4,275,266.56 |
| 销售费用 | 128,148,259.64 | 86,358,122.66 | 40,476,044.87 | 187,697,083.27 |
| 管理费用 | 86,766,589.09 | 58,448,364.38 | 29,204,583.3 | 138,838,602.42 |
| 研发费用 | 1,875,002 | 1,250,004 | 625,006 | 3,580,360.61 |
| 财务费用 | 26,661,188.27 | 18,271,139.41 | 9,253,611.22 | 39,152,824.85 |
| 其中:利息费用 | 25,958,366.96 | 17,881,928.34 | 8,982,567.81 | 38,379,206.64 |
| 其中:利息收入 | 420,348.59 | 324,586.36 | 107,217.96 | 636,631.11 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 9,522,973.17 | 4,682,389.73 | 2,587,132.19 | 14,768,363.72 |
| 资产处置收益 | 653,964.74 | 342,994.13 | 1,397.07 | 5,020,865.74 |
| 资产减值损失(新) | 104,514.06 | -16,266.59 | 374,869.55 | -133,155,370.85 |
| 信用减值损失(新) | 2,130,730.66 | 1,494,082.95 | 1,201,040.93 | -3,408,297.1 |
| 其他收益 | 1,178,282.67 | 683,075.35 | 286,291.34 | 4,890,451.74 |
| 四、营业利润 | 7,758,876.53 | 4,630,620.51 | 1,815,267.38 | -156,481,533.01 |
| 加:营业外收入 | 1,341,606.32 | 1,207,873.84 | 76,022.67 | 567,090.96 |
| 减:营业外支出 | 3,949,062.69 | 2,736,086.35 | 654,737.54 | 5,172,305.87 |
| 五、利润总额 | 5,151,420.16 | 3,102,408 | 1,236,552.51 | -161,086,747.92 |
| 减:所得税费用 | 4,771,413.72 | 2,091,829.84 | 495,171.23 | 13,890,014.65 |
| 六、净利润 | 380,006.44 | 1,010,578.16 | 741,381.28 | -174,976,762.57 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 380,006.44 | 1,010,578.16 | 741,381.28 | -174,976,762.57 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 173,418.14 | 1,418,926.14 | 573,756.72 | -174,653,435.06 |
| 少数股东损益 | 206,588.3 | -408,347.98 | 167,624.56 | -323,327.51 |
| 扣除非经常损益后的净利润 | -9,175,309.61 | -3,279,782.89 | -1,593,569.15 | -194,526,829.68 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0 | 0 | 0 | -0.34 |
| (二)稀释每股收益 | 0 | 0 | 0 | -0.34 |
| 八、其他综合收益 | - | - | - | 408,800 |
| 归属于母公司股东的其他综合收益 | - | - | - | 408,800 |
| 九、综合收益总额 | 380,006.44 | 1,010,578.16 | 741,381.28 | -174,567,962.57 |
| 归属于母公司股东的综合收益总额 | 173,418.14 | 1,418,926.14 | 573,756.72 | -174,244,635.06 |
| 归属于少数股东的综合收益总额 | 206,588.3 | -408,347.98 | 167,624.56 | -323,327.51 |
| 公告日期 | 2025-10-24 | 2025-08-22 | 2025-04-28 | 2025-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |